Abstract
Previous studies have demonstrated that much of the immunomodulatory activity of the glycoprotein uromodulin can be attributed to attached oligosaccharides. Structural studies of isolated and purified saccharides derived from uromodulin suggest that the structure Man6GlcNAc2-asn can inhibit in vitro assays of antigen driven T cell proliferation. Based on these observations, we isolated a series of high mannose glycopeptides from a variety of natural sources and tested them for biologic activity in a number of assays. We found that purified mannose rich glycopeptides are able to activate the hexose monophosphate (HMP)shunt, induce prostaglandin synthesis, and directly stimulate IL-1 synthesis. These in vitro effects appear to have in vivo counterparts. Thus in a species-restricted fashion, high mannose compounds are able to directly activate a delayed mononuclear cell infiltrate after intradermal injection. Our data suggest that specific mannose oligosaccharides may activate as well as inhibit cellular immune responses at several different levels. These findings support the hypothesis that specific saccharide structures could participate in the physiologic regulation of the immune response.
Similar content being viewed by others
References
Dinarello CA: The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol Lett 16: 227–231, 1987
Sherry B, Tekamp-Olson P, Gallagos C, Bauer D, Davatelis G, Wolpe SD, Masiarz F, Coit D, Cerami A: Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med 168: 2251–2259, 1988
Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB, Shepard HM: Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res 47: 780–786, 1987
Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggit D: Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol 128: 410–425, 1987
Doebber TW, Wu MS, Biftu T: Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. J Immunol 136: 4659–4668, 1986
Braquet P: Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane. Leukotriene Res 16, 1986
Gebhardt BM, Braquet P, Bazan H, Bazan N: Modulation of in vitro reactions by platelet activating factor and a platelet activating factor antagonist. Immunopharmacology 15: 11–19, 1988
Muchmore AV, Decker JM, Blaese RM: Evidence that specific oligosaccharides block early events necessary for the expression of antigen-specific proliferation by human lymphocytes. J Immunol 125: 1306–1311, 1980
Muchmore AV, Decker JM, Blaese RM: Spontaneous cytotoxicity by human peripheral blood monocytes: inhibition by monosaccharides and oligosaccharides. Immunobiology 158: 191–206, 1981
Decker JM, Elmholt A, Muchmore AV: Spontaneous cytotoxicity mediated by invertebrate mononuclear cells toward normal and malignant vertebrate targets: inhibition by defined mono- and disaccharides. Cell Immunol 59: 161–170, 1981
MacDermott RP, Kienker LJ, Bertovich MJ, Muchmore AV: Inhibition of spontaneous but not antibody dependent cell-mediated cytotoxicity by simple sugars: evidence that endogenous lectins may mediate spontaneous cell-mediated cytotoxicity. Immunology 44: 143–152, 1981
Muchmore AV, Decker JM: Evidence that recombinant IL-1 alpha exhibits lectin-like specificity and binds to homogeneous uromodulin via N-linked oligosaccharides. J Immunol 138: 2541–2546, 1987
Sherblom AP, Decker JM, Muchmore AV: The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J Biol Chem 263: 5418–5424, 1988
Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243: 1160–1165, 1989
Siegelman MH, van de Rijn M, Weissman IL: Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. Science 243: 1165–1172, 1989
Ezekowitz RA, Day LE, Herman GA: A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med 167: 1034–1046, 1988
Muchmore AV, Shifrin S, Decker JM: In vitro evidence that carbohydrate moieties derived from uromodulin, an 85,000 dalton immunosuppressive glycoprotein isolated from human pregnancy urine, are immunosuppressive in the absence of intact protein. J Immunol 138: 2547–2553, 1987
Muchmore AV, Sathyamoorthy N, Decker JM, Sherblom AP: Evidence that specific high mannose oligosaccharides are able to directly inhibit antigen driven T cell responses. J Leuk Biol 48: 457–464 (1990)
Sherblom AP, Van Halbeek H, Muchmore AV: Structural characterization of high mannose oligosaccharides derived from Uromodulin (submitted)
Serafini-Cessi F, Dall'Olio F, Malagolini N: High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein. Biosci. Rep 4: 269–274, 1983
Dall'Olio F, de Kanter FJ, van den Eijnden DH, Serafini-Cessi F: Structural analysis of the preponderant high-mannose oligosaccharide of human Tamm-Horsfall glycoprotein. Carbohydr Res 178: 327–332, 1988
Huang CC, Mayer HE, Montgomery R: Microheterogeneity and paucidispersity of glycoproteins. Carbohydr Res 13: 127–137, 1970
Lis H, Sharon N: Soybean agglutinin -a plant glycoprotein. Structure of the carbohydrate unit. J Biol Chem 253: 3468–3476, 1978
Sherblom AP, Sathyamoorthy N, Decker JM, Muchmore AV: IL-2, a lectin with specificity for high mannose glycopeptides. J Immunol 143: 939–944, 1989
Rook GA, Steele J, Umar S, Dockrell HM: A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma interferon. J Immunol Meth 82: 161–167, 1985
Vretblad P: Purification of lectins by biospecific affinity chromatography. Biochim Biophys Acta 434: 169–176, 1976
Tai T, Yamashita K, Ito S, Kobata A: Structures of the carbohydrate moiety of ovalbumin glycopeptide III and the difference in specificity of endo-beta-N-acetylgluco-saminidases CII and H. J Biol Chem 252: 6687–6694f, 1977
Stobo JD, Paul S, Van Scoy RE, Hermans PE: Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest 57: 319–328, 1976
Fischer A, Ballet JJ, Griscelli C: Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest 62: 1005–1013, 1978
Williams DL, Sherwood ER, McNamee RB, Jones EL, Browder IW, DiLuzio NR: Chemoimmunotherapy of experimental hepatic metastases. Hepatology 7: 1296–1304, 1989
Seljelid R: Tumor regression after treatment with aminated beta 1–3D polyglucose is initiated by circulatory failure. Scand J Immunol 29: 181–192, 1989
Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae: Immunomodulation by orally administered beta-glucan in mice. Intl J Immunopharmacol 11: 761–769, 1989
Sugawara I, Lee KC: Fucoidan blocks macrophage activation in an inductive phase but promotes macrophage activation in an effector phase. Microbiol Immunol 28: 371–377, 1984
Rosoff PM, Savage N, Dinarello CA: Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism. Cell 54: 73–81, 1988
Tsujimoto M, Tanaka S, Sakuragawa Y, Tsuruoka N, Funakoshi K, Butsugan T, Nakazato H, Nishihara T, Noguchi T, Vil:cek J: Comparative studies of the biological activities of human tumor necrosis factor and its derivatives. J Biochem (Tokyo) 101: 919–925, 1987
Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM: Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943–945, 1985
Bowlin TL, Sunkara PS: Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes. Biochem Biophys Res Commun 151: 859–864, 1988
Bowlin TL, McKown BJ, Kang MS, Sunkara PS: Potentiation of human lymphokine-activated killer cell activity by Swainsonine, an inhibitor of glycoprotein processing. Cancer Res 49: 4109–4113, 1989
Humphries MJ, Matsumoto K, White SL, Molyneux RJ, Olden K: Augmentation of murine natural killer cell activity by Swainsonine, a new antimetastatic immunomodulator. Cancer Res 48: 1410–1415, 1988
Newton SA, White SL, Humphries MJ, Olden K: Swainsonine inhibition of spontaneous metastasis. J Natl Cancer Inst 81: 1024–1028, 1989
White SL, Schweitzer K, Humphries MJ, Olden K: Stimulation of DNA synthesis in murine lymphocytes by the drug Swainsonine: immunomodulatory properties. Biochem Biophys Res Commun 150: 615–625, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sathyamoorthy, N., Decker, J.M., Sherblom, A.P. et al. Evidence that specific high mannose structures directly regulate multiple cellular activities. Mol Cell Biochem 102, 139–147 (1991). https://doi.org/10.1007/BF00234571
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00234571